| McAlpine's multiple sclerosis A Compston, C Confavreux, H Lassmann, I McDonald, D Miller, ... Churchill Livingstone Elsevier, 2005 | 1127* | 2005 |
| The neurobiology of multiple sclerosis A Compston, H Lassmann, KJ Smith McAlpine's multiple sclerosis, 4th edition, 449-490, 2006 | 868* | 2006 |
| MCALPINE’S MULTIPLE SCLEROSIS 4TH EDN A COMPSTON, I MCDONALD, J NOSEWORTHY, H LASSMANN, ... BRITISH JOURNAL OF NEUROSCIENCE NURSING 2 (3), 149, 2006 | 849* | 2006 |
| Demyelination: the role of reactive oxygen and nitrogen species KJ Smith, R Kapoor, PA Felts Brain Pathology 9 (1), 69-92, 1999 | 749 | 1999 |
| The role of nitric oxide in multiple sclerosis KJ Smith, H Lassmann The Lancet Neurology 1 (4), 232-241, 2002 | 676 | 2002 |
| Pathogenesis of Guillain–Barré syndrome RAC Hughes, RDM Hadden, NA Gregson, KJ Smith Journal of neuroimmunology 100 (1-2), 74-97, 1999 | 545 | 1999 |
| Perivascular spaces in the brain: anatomy, physiology and pathology JM Wardlaw, H Benveniste, M Nedergaard, BV Zlokovic, H Mestre, H Lee, ... Nature Reviews Neurology 16, 137–153, 2020 | 480 | 2020 |
| The pathophysiology of multiple sclerosis⋮ the mechanisms underlying the production of symptoms and the natural history of the disease KJ Smith, WI McDonald Philosophical Transactions of the Royal Society of London B: Biological …, 1999 | 427 | 1999 |
| Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. EJ Redford, R Kapoor, KJ Smith Brain: a journal of neurology 120 (12), 2149-2157, 1997 | 418 | 1997 |
| Central remyelination restores secure conduction KJ Smith, WF Blakemore, WI McDonald Nature 280 (5721), 395-396, 1979 | 400 | 1979 |
| Electrically active axons degenerate when exposed to nitric oxide KJ Smith, R Kapoor, SM Hall, M Davies Annals of neurology 49 (4), 470-476, 2001 | 399 | 2001 |
| Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? C Marik, PA Felts, J Bauer, H Lassmann, KJ Smith Brain 130 (11), 2800-2815, 2007 | 339 | 2007 |
| Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration R Kapoor, M Davies, PA Blaker, SM Hall, KJ Smith Annals of neurology 53 (2), 174-180, 2003 | 326 | 2003 |
| Neuroprotection and repair in multiple sclerosis RJM Franklin, C ffrench-Constant, JM Edgar, KJ Smith Nature Reviews Neurology 8 (11), 624-634, 2012 | 302 | 2012 |
| Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial R Kapoor, J Furby, T Hayton, KJ Smith, DR Altmann, R Brenner, ... The Lancet Neurology 9 (7), 681-688, 2010 | 295 | 2010 |
| Understanding the role of the perivascular space in cerebral small vessel disease R Brown, H Benveniste, SE Black, S Charpak, M Dichgans, A Joutel, ... Cardiovascular research 114 (11), 1462-1473, 2018 | 279 | 2018 |
| A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology M Matarin, DA Salih, M Yasvoina, DM Cummings, S Guelfi, W Liu, ... Cell reports 10 (4), 633-644, 2015 | 271 | 2015 |
| Conduction in segmentally demyelinated mammalian central axons PA Felts, TA Baker, KJ Smith Journal of Neuroscience 17 (19), 7267-7277, 1997 | 262 | 1997 |
| Axonal protection using flecainide in experimental autoimmune encephalomyelitis DA Bechtold, R Kapoor, KJ Smith Annals of neurology 55 (5), 607-616, 2004 | 225 | 2004 |
| The restoration of conduction by central remyelination. KJ Smith, WF Blakemore, WI McDonald Brain: a journal of neurology 104 (2), 383-404, 1981 | 222 | 1981 |
Michael R DuchenUCLVerified email at ucl.ac.uk
